Thomas J. Falk's most recent trade in Abbvie Inc was a trade of 1,203 Common Stock, $0.01 par value done . Disclosure was reported to the exchange on May 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie Inc | Thomas J. Falk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 1,203 | 1,203 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Lockheed Martin Corp | Thomas J. Falk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 401 | 14,767 | - | - | Phantom Stock Units | |
| Lockheed Martin Corp | Thomas Falk J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 401 | 14,000 | - | - | Phantom Stock Units | |
| Lockheed Martin Corp | Thomas J. Falk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 353 | 13,236 | - | - | Phantom Stock Units | |
| Lockheed Martin Corp | Thomas J. Falk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 417 | 12,556 | - | - | Phantom Stock Units | |
| Lockheed Martin Corp | Thomas J. Falk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 501 | 11,788 | - | - | Phantom Stock Units |